Form4insider filings, from the source

Insider holders · CIK 0001439222

AGIOS PHARMACEUTICALS, INC. · AGIO

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Celgene Switzerland LLC10% Owner1,374,5995,343,8346,718,433Jan 31, 2018 · 8:39 am ESTForm 4/A
Celgene Alpine Investment Co., LLC10% Owner1,374,5995,343,8346,718,433Jan 31, 2018 · 8:39 am ESTForm 4/A
Celgene European Investment Co LLC10% Owner1,374,5995,343,8346,718,433Jan 31, 2018 · 8:39 am ESTForm 4/A
CELGENE CORP10% Owner1,374,5995,343,8346,718,433Jan 31, 2018 · 8:39 am ESTForm 4/A
ARCH Venture Partners VII, L.P.10% Owner3,088,590—3,088,590Feb 23, 2015 · 4:56 pm ESTForm 4
ARCH Venture Partners VII, LLC10% Owner3,088,590—3,088,590Feb 23, 2015 · 4:56 pm ESTForm 4
Arch Venture Fund VII LP10% Owner3,088,590—3,088,590Feb 23, 2015 · 4:56 pm ESTForm 4
Clinton Bybee10% Owner3,088,590—3,088,590Feb 23, 2015 · 4:56 pm ESTForm 4
Keith Crandell10% Owner3,088,590—3,088,590Feb 23, 2015 · 4:56 pm ESTForm 4
Kevin P StarrDirector184,3860184,386Feb 19, 2015 · 7:01 pm ESTForm 4
David P SchenkeinDirector89,50379,082168,585Feb 20, 2019 · 4:07 pm ESTForm 4
Jacqualyn A FouseDirector154,156—154,156Jun 23, 2026 · 5:22 pm EDTForm 4
John Duncan HiggonsChief Operating Officer120,834—120,834Jan 5, 2016 · 5:20 pm ESTForm 4
Robert NelsenDirector109,2300109,230Mar 7, 2017 · 4:35 pm ESTForm 4
Lewis Clayton Cantley Jr.Director79,47520,803100,278Dec 8, 2017 · 4:23 pm ESTForm 4
Scott BillerChief Scientific Officer26,51153,05979,570Mar 7, 2019 · 4:06 pm ESTForm 4
Sarah GheuensChief Medical Officer54,645—54,645Aug 6, 2026 · 4:13 pm EDTForm 4
John MaraganoreDirector36,209—36,209Nov 6, 2018 · 4:12 pm ESTForm 4/A
David ScaddenDirector20,419—20,419Jun 23, 2026 · 5:20 pm EDTForm 4
Maykin HoDirector19,848—19,848Jun 23, 2026 · 5:21 pm EDTForm 4
Rahul D. BallalDirector15,230—15,230Jun 23, 2026 · 5:25 pm EDTForm 4
Cynthia SmithDirector15,230—15,230Jun 23, 2026 · 5:19 pm EDTForm 4
Kaye I Foster-CheekDirector10,2842,20012,484Jun 23, 2026 · 5:23 pm EDTForm 4
Andrew HirschChief Financial Officer12,374—12,374Feb 20, 2019 · 4:05 pm ESTForm 4
Steven L. HoerterChief Commercial Officer10,941—10,941Mar 5, 2019 · 4:04 pm ESTForm 4
Adams Catherine OwenDirector10,865—10,865Jun 23, 2026 · 5:21 pm EDTForm 4
Jeffrey D CapelloDirector10,865—10,865Jun 23, 2026 · 5:24 pm EDTForm 4
Christopher BowdenChief Medical Officer7,195—7,195Feb 20, 2019 · 4:04 pm ESTForm 4
Carman AlensonPrincipal Accounting Officer2,796—2,796Feb 25, 2019 · 4:03 pm ESTForm 4
Douglas G. ColeDirector2,778—2,778Aug 11, 2016 · 4:33 pm EDTForm 4
Jay T. BackstromDirector1,447—1,447Jul 10, 2026 · 4:18 pm EDTForm 4
Glenn GoddardSenior Vice President, Finance0—0Sep 28, 2015 · 5:15 pm EDTForm 4
Third Rock Ventures GP, L.P.10% Owner0—0Feb 19, 2015 · 7:03 pm ESTForm 4
TRV GP, LLC10% Owner0—0Feb 19, 2015 · 7:03 pm ESTForm 4
THIRD ROCK VENTURES LP10% Owner0—0Feb 19, 2015 · 7:03 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.